Centiva Capital’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,806
Closed -$80.7K 1762
2025
Q1
$80.7K Sell
17,806
-16,875
-49% -$89.3K ﹤0.01% 1418
2024
Q4
$245K Sell
34,681
-5,164
-13% -$41.1K 0.01% 1258
2024
Q3
$324K Buy
+39,845
New +$288K 0.01% 1528
2024
Q2
Sell
-46,379
Closed -$349K 2246
2024
Q1
$349K Buy
+46,379
New +$423K 0.01% 1169

Other funds holding HCAT

Centiva Capital's HCAT Position: Q2 2025 in Review

Centiva Capital sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 17,806 shares — an estimated $80.7K sold.

Centiva Capital first reported a position in HCAT in Q1 2024 and held it in 4 quarters. The position peaked at $349K in Q1 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • Centiva Capital reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 17,806 Health Catalyst shares in Q2 2025, an estimated $80.7K.
  • Centiva Capital first reported a position in Health Catalyst in Q1 2024 and held it in 4 quarters.
  • Centiva Capital's Health Catalyst position peaked at $349K in Q1 2024.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.